Rise of Clinical Trials Industry in India: An Analysis
Table 1
Resource advantages as destination for clinical trials.
Investigators
(i) Large no. of specialists in different therapy segments (ii) Medical training in English (iii) 600,000 English speaking physicians (iv) PG training from Europe/US (v) Treatment protocols in line with west (vi) Large no. of ICH/GCP complaint investigators/sites
Patient population
(i) Large, diverse, therapy-naïve (ii) Advantage of having 6 out of 7 genetic varieties (iii) Large pt. pool in acute/chronic disease segment (iv) Increasing no. of pts in life style disorders segment, HIV, oncology
Clinical research infrastructure
(i) Over 200 medical colleges (ii) Over 22,000 graduates per year (iii) 15,622 hosp., 903,952 hosp. beds >75% in urban area (iv) 14000 diagnostic labs (v) 700,000 scientists and engineering graduates/year (vi) World class medical/lab facilities at secondary/tertiary care centers (vii) Skilled computer savvy biomedical work force
IT support
(i) Highly developed IT/ITES (ii) Motivated and committed personnel
Connectivity
(i) High quality digital connectivity (ii) Excellent air/surface transport facilities across country
